Lichen Planus: What is New in Diagnosis and Treatment?
Lichen planus (LP), an idiopathic, multifaceted chronic inflammatory disease with a
heterogeneous clinical presentation, affects approximately 0.5–1% of the population. The …
heterogeneous clinical presentation, affects approximately 0.5–1% of the population. The …
Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
M Starace, S Cedirian, L Rapparini, F Quadrelli… - Dermatology and …, 2024 - Springer
Frontal fibrosing alopecia (FFA) represents a distinctive form of primary lymphocytic scarring
alopecia characterized by fronto-temporal hair recession and eyebrow hair loss. While …
alopecia characterized by fronto-temporal hair recession and eyebrow hair loss. While …
[HTML][HTML] The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
Discussion Topical ruxolitinib 1.5% cream currently stands as the sole FDA-approved topical
JAK inhibitor formulation in the United States, having received approval in September 2021 …
JAK inhibitor formulation in the United States, having received approval in September 2021 …
Alopezie-ein altes Problem mit neuen Behandlungsoptionen.
U Wollina - Kosmetische Medizin+ Ästhetische Chirurgie, 2024 - search.ebscohost.com
Die Alopezie kann grob in narbige und nichtvernarbende Varianten unterteilt werden.
Größte Bedeutung unter den nichtvernarbenden Erkrankungen habe die Alopecia areata …
Größte Bedeutung unter den nichtvernarbenden Erkrankungen habe die Alopecia areata …
[HTML][HTML] QUESTION OF THE WEEK
LC Chen - donovanmedical.com
Oral and topical JAK inhibitors continue to be studied in scarring alopecia. A small number
of studies point to potential benefits of oral and topical JAK inhibitors in the treatment of …
of studies point to potential benefits of oral and topical JAK inhibitors in the treatment of …